$1.03
-0.015-1.43%
Last update: Oct 1, 9:29 AM
$1.09
0.043.81%
Pliant Therapeutics Inc
PLRXNASDAQ
Pliant Therapeutics (PLRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.34 | $-0.36 | $-0.40 | $-0.53 |
| Actual | $-0.36 | $-0.32 | $-0.38 | $-0.43 |
| Surprise | -5.88% | +11.1% | +5.00% | +18.9% |
| Revenue | ||||
| Estimate | — | — | $3.3M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.37 | $-0.37 | $-0.38 | $-0.38 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.36 | $-0.34 | -5.88 % |
| Q1 | May 11, 2026 | $-0.32 | $-0.36 | 11.1 % |
| Q4 | Mar 11, 2026 | $-0.38 | $-0.40 | 5.00 % |
| Q3 | Nov 6, 2025 | $-0.43 | $-0.53 | 18.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 11, 2026 | $0 | $3.33M | -100.0 % |
| Q1 | May 8, 2025 | $0 | $333.33K | -100.0 % |
| Q4 | Mar 3, 2025 | $0 | $83.33K | -100.0 % |
| Q3 | Nov 7, 2024 | $0 | $530.00K | -100.0 % |
